Testosterone undecanoate injection, a rare cause of diffuse alveolar hemorrhage: A case report from Almoosa Hospital

---

Case Report

Author Details : Safwat A.M. Eldaboosy*, Amged Awad

Volume : 6, Issue : 2, Year : 2021

Article Page : 133-136

https://doi.org/10.18231/j.ijirm.2021.029

Suggest article by email

Get Permission

---

Abstract

Many systemic and few respiratory (cough, pulmonary embolism) adverse effects follow anabolic agent use. Pulmonary hemorrhage is not considered one among them. We present a case of an adult Saudi male who developed diffuse alveolar hemorrhage (DAH) as a results of the utilization of injectable anabolic steroid hormone replacement therapy. The literature reported only three cases of DAH related to anabolic agent abuse. The patient was presented with acute dyspnea and hemoptysis with diffuse alveolar shadow on chest radiograph. The symptoms promptly resolved with cessation of exposure and recurrent after the reuse. Pulmonary hemorrhage as an acute complication of anabolic agent use must be considered when clinical and radiological findings support it. It’s important to rule out the autoimmune and infectious-related causes before considering it drug-related.

Keywords: Testosterone, Diffuse alveolar hemorrhage.

How to cite : Eldaboosy S A, Awad A , Testosterone undecanoate injection, a rare cause of diffuse alveolar hemorrhage: A case report from Almoosa Hospital. IP Indian J Immunol Respir Med 2021;6(2):133-136

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.